No Detail Found!

Evaluation of pharmacist's knowledge regarding chronic kidney disease

Author(s)
Syed Azhar Syed Sulaiman Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia; Advance Medical and Dental Institute, Universiti Sa ins Malaysia, Bertam, Penang, Malaysia.
Muhammad Haseeb Tariq Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia,11800 Penang,Malaysia
Abstract
Background: Chronic Kidney Disease is a complex condition characterized by a decrease in kidney function. Objective: The objective of this study was to develop and validate a knowledge tool and assess the knowledge of pharmacists regarding Chronic Kidney Disease (CKD). Methods: The study consisted of 2 phases with phase-I involving the development and validation of a knowledge tool. The development phase encompassed a thorough review of the literature, focus-group discussion, and expert review. The validation phase consisted of pilot testing and involving content and face validity and reliability testing using Cronbach alpha. Phase-II involved an assessment of knowledge of pharmacists by administering the validated tool to 183 practicing pharmacists working in tertiary care hospitals in 3 big cities of Pakistan. The data obtained were statistically analyzed involving descriptive and inferential statistics including chi-square test, one way ANOVA, post hoc Tukey's test, and regression analysis. Results: The developed knowledge was found to be reliable with Cronbach alpha values above 0.7 during the pilot testing. A high response rate of 93.4% was observed during the study. 50.9% of the pharmacists in the study had good knowledge, the mean percent knowledge score was found to be 54.76. The knowledge score was found to be associated with the male gender, 30 - 39 years of age, >5 years of experience and clinical / hospital pharmacy certification during the post hoc analysis (p<005). Strong positive correlation and linear regression relationship were observed between percentage knowledge score and number of years of professional clinical experience. Conclusions: Pharmacists working in tertiary care hospitals in Pakistan exhibit a good knowledge of chronic kidney disease.
Publication Details
Page(s) 1-8
DOI DOI not available
Published Journal: Archives of Pharmacy Practice, Volume: 11, Issue: 4, Year: 2020

Request the full text from PASTIC

Keywords
Chronic Kidney Disease, Clinical pharmacy, Validation, Knowledge, Questionnaire, Reliability
References
Levin A.,Stevens P.E.,Bilous R.W.,Coresh J.,Griffith A.LM.,Hemmelgarn K.E.,Iseki B.R.,Lamb K.,E.J. K. .2013 .KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney international supplements, 3(1) : 1-150.
Weiner D.E.,Tighiouart H.,Amin M.G.,Stark P.C.,MacLeod B.,Griffith J.L.,Salem D.N.,Levey A.S.,Sarnak M.J. .2004 .Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Journal of the American Society of Nephrology, 15(5) : 1307-1315.
Saeed S,Islahudin F,Makmor-Bakry M,Redzuan AM . .The practice of complementary and alternative medicine among chronic Kidney disease patients. J. Adv. Pharm. Educ. Res. 2018 Jan, 1(3) : 30-36.
Turkistani YA,Alshami TM,Almatrafi SJ,Alahmadi AO,Edrisy A,Hashem SA,Bazuhair GY,Rajab FH,Alqawain AH,Jalawi BA,Hashem SA . .Evaluation of Contrast-Induced Acute Kidney Injury (CIAKI): A Literature Review. Int. J. Pharm. Res. Allied Sci. 2020 Jan, 1(1) : 99-104.
Ojo A. .2014 .Addressing the global burden of chronic kidney disease through clinical and translational research. Transactions of the American Clinical and Climatological Association, 125 : 229.
Naghavi M.,Wang H.,Lozano R.,Davis S.,Liang X.,Zhou M.,Vollset S.E.,Ozgoren A.A.,Abdalla S.,Abd-Elmotelib F. .2015 .Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global. Burden of Disease Study, : .
Vos T.,Barber R.M.,Bell B.,Bertozzi-Villa A.,Biryukov S.,Bolliger I.,Charlson F.,Davis A.,Degenhardt L.,Dicker D. .2015 .a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 386(9995) : 743-800.
Jha V.,Garcia-Garcia G.,Iseki K.,Li Z.,Naicker S.,Plattner B.,Saran R.,Wang A.,Yang C. .2013 .Chronic kidney disease: global dimension and perspectives. The Lancet, 382(9888) : 260-272.
Nugent R.A.,Fathima S.F.,Feigl A.B.,Chyung D. .2011 .The burden of chronic kidney disease on developing nations: a 21st-century challenge in global health. Nephron Clinical Practice, 118(3) : c269-c277.
AlSogair AA,Alharbi AA,Alharbi SH,Alateeq FA,Aloriney AM,Ahmed HG .2019 .Knowledge and Perceptions Toward Chronic Kidney Disease Prevention and Control in Saudi Arabia. International Int. J. Pharm. Res. Allied Sci, 8(1) : 77-83.
Zayet GK .2018 .Serum Hepatocytes growth factor in acute and chronic Kidney diseasepatients and its relation to disease activity. J. Adv. Pharm. Educ. Res, 8(3) : 74-80.
Levin A.,Stevens P. E. .2011 .Early detection of CKD: the benefits, limitations, and effects on prognosis. Nature Reviews Nephrology, 7(8) : 446.
Stemer G.,Lemmens-Gruber R. .2011 .Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC nephrology, 12(1) : 35.
Kharkar M.,Bowalekar S. .2012 .Knowledge, attitude, and perception/practices (KAP) of medical practitioners in India towards adverse drug reaction (ADR) reporting. Perspectives in clinical research, 3(3) : 90.
Jadoo S.A.A.,Sulku S.N.,Aljunid S.M.,Dastan I. .2014 .Validity and reliability analysis of knowledge of, attitude toward, and practice of a case-mix questionnaire among Turkish healthcare providers. Journal of Health Economics and Outcomes Research, 2(1) : 96-107.
Agrawal V.,Ghosh A.K.,Barnes M.A.,McCullough P.A.,Awareness P.A. .2008 .knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. American journal of kidney diseases, 52(6) : 1061-1069.
Alrabiah A.M.,Elsaid T.,Tourkmani A. .2018 .Determinants of family medicine physicians' knowledge and application of asthma management guidelines at primary healthcare centers in Riyadh, Saudi Arabia. Journal of Family Medicine and Primary Care, 7(5) : 927.
Jamshed S. .2008 .Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan? Pharmacy world. , 30(5) : 617-619.
Hadi M.A.,Hughes J. .2009 .Broader perspective needed on the PharmD degree in Pakistan. American journal of pharmaceutical education, 73(6) : .
Jamshed S.,Izham M.,Ibrahim M. .2009 .PharmD in Pakistan: a tag or a degree? American journal of pharmaceutical education. , 73(1) : 2.
Valdez C.,Namdar R.,Valuck R. .2013 .Impact of pharmacy experience, GPA, age, education, and therapeutic review on knowledge retention and clinical confidence. Currents in Pharmacy Teaching and Learning, 5(5) : 358-364.
Fekadu G.,Gamachu B.,Mengie T.,Maqbool M. .2019 .Knowledge, attitude of health care professional's towards clinical pharmacy services in Nedjo General Hospital, Western Ethiopia. International Journal, 5(7) : 172.
Madiha M.,Yang C.-Q.,Curriculum C.-Q. .2014 .Pharmacy practice experience offered for Pharm-D in Pakistan: needs and possibilities. International Current Pharmaceutical Journal, 3(8) : 313-317.
0

Citations

0

Downloads

10

Views